Brimonidine

Primary Uses

Brimonidine is primarily used to reduce elevated intraocular pressure (pressure inside the eye). Lowering this pressure is essential for preventing damage to the optic nerve and protecting vision. It is commonly prescribed for the following conditions:

• Open-angle glaucoma: A chronic eye condition where fluid does not drain correctly, leading to increased pressure.
• Ocular hypertension: A state where the pressure inside the eye is higher than the normal range, which increases the risk of developing glaucoma.

Combination Therapy

For some patients, brimonidine may be used in combination with other eye medications, such as timolol or brinzolamide. These combination products are used when a single medication is not sufficient to lower eye pressure to a safe level.

Relief of Eye Redness

Specific low-dose formulations of brimonidine are available over-the-counter to treat eye redness. These products work by narrowing the blood vessels in the eye to reduce the appearance of redness caused by minor irritations.

Mechanism of Action

Brimonidine belongs to a class of medications known as alpha-adrenergic agonists. It is primarily used to treat high pressure inside the eye, which can occur in conditions such as glaucoma or ocular hypertension. If left untreated, this pressure can damage the optic nerve and lead to vision loss.

The medication works in two ways to manage eye pressure:

• Reducing fluid production: It decreases the amount of aqueous humor, which is the natural fluid produced in the front part of the eye.
• Improving fluid drainage: It increases the flow of fluid out of the eye through its natural drainage pathways.

By both limiting the creation of new fluid and helping existing fluid leave the eye, brimonidine helps maintain a healthy pressure level within the eyeball.

Common Side Effects

Many people using brimonidine experience mild side effects. These often go away as the body adjusts to the medication. Common side effects include:

• Eye redness, stinging, burning, or itching
• Blurred vision
• Dry mouth
• Drowsiness or tiredness
• Headache
• Dizziness
• Feeling like something is in the eye

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious side effects:

• Severe eye pain, swelling, or crusting
• Significant changes in vision
• Irregular or fast heartbeat
• Fainting or severe dizziness
• Signs of an allergic reaction, such as a rash, hives, or swelling of the face, lips, or tongue

In infants and young children, brimonidine can cause extreme drowsiness, a drop in body temperature, or slowed breathing. Seek emergency medical help if these symptoms occur in a child.

Pediatric Warning

Brimonidine is contraindicated for use in children under the age of 2 years. In young children, the medication can cause serious central nervous system depression, including extreme sleepiness, limpness, low body temperature, and slowed breathing. It should be used with extreme caution in children aged 2 and older.

Contraindications and Interactions

This medication should not be used by individuals with a known hypersensitivity to brimonidine tartrate or any of its ingredients. It is also contraindicated for those currently taking monoamine oxidase (MAO) inhibitor therapy.

Pre-existing Conditions

Caution is advised for individuals with certain medical histories, as brimonidine may worsen these conditions or increase the risk of side effects:

• Severe cardiovascular disease
• Cerebral or coronary insufficiency
• Raynaud's phenomenon
• Orthostatic hypotension (a significant drop in blood pressure when standing)
• Thromboangiitis obliterans
• Depression
• Severe kidney or liver impairment

General Precautions

Drowsiness and Alertness: Brimonidine may cause fatigue or drowsiness in some patients. Caution is recommended when driving, operating machinery, or performing hazardous activities that require mental alertness.

Contact Lenses: The preservative used in many brimonidine eye drops can be absorbed by soft contact lenses and may cause discoloration. Lenses should be removed before using the drops and may be reinserted 15 minutes after the dose is applied.

Contamination: To prevent eye infections or damage to the eye, the tip of the dispenser should not touch any surface, including the eye, eyelids, or hands.

Pregnancy

There are no adequate and well-controlled studies of brimonidine use in pregnant women. While animal studies have not shown evidence of harm to the developing fetus at high doses, results from animal research do not always predict how a drug will affect humans. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of using this medication with your healthcare provider. Brimonidine should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.

Breastfeeding

It is not known whether brimonidine passes into human breast milk. However, animal studies have shown that the medication is excreted in the milk of lactating rats. Because of the potential for adverse reactions in nursing infants, a decision should be made with a healthcare provider about whether to stop breastfeeding or stop using the medication, considering the importance of the treatment to the mother.

Ophthalmic Solution

Brimonidine tartrate is most commonly available as a sterile eye drop solution. It is provided in several strengths, including:

• 0.1%
• 0.15%
• 0.2%

Brimonidine is also available as a combination ophthalmic solution with other medications, such as brinzolamide or timolol.

Topical Gel

Brimonidine is available as a topical gel for application to the skin. This form is typically used for facial redness and is available in a 0.33% strength.

FDA Approval and Indications

Brimonidine tartrate ophthalmic solution is approved by the U.S. Food and Drug Administration (FDA) to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. By reducing fluid production and increasing drainage, it helps prevent damage to the optic nerve.

Formulations and Availability

• Prescription Use: Concentrations of 0.1%, 0.15%, and 0.2% are available as prescription-only eye drops for the management of intraocular pressure.
• Over-the-Counter Use: A 0.025% concentration is FDA-approved for over-the-counter sale to relieve eye redness.
• Combination Products: The FDA has approved fixed-dose combinations of brimonidine with other glaucoma medications, including timolol and brinzolamide, for patients who need additional pressure control.

Safety Oversight

The FDA does not currently require a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) for brimonidine ophthalmic products. However, regulatory labeling includes a contraindication for use in children under 2 years of age because of the potential for serious systemic side effects, such as respiratory depression and coma.

Uses for Eye Pressure

Brimonidine ophthalmic solution is primarily prescribed to treat open-angle glaucoma and ocular hypertension. It works by decreasing the production of fluid in the eye and improving the drainage of fluid, which helps prevent vision loss from high intraocular pressure.

Uses for Eye Redness

Low-dose brimonidine eye drops are available over-the-counter to temporarily relieve redness of the eye caused by minor irritations. These drops work by narrowing the blood vessels in the eye to reduce the appearance of redness.

Administration and Care

• Wash your hands before and after using the drops.
• Do not touch the dropper tip to any surface, including your eye or hands, to avoid contamination.
• If you wear soft contact lenses, remove them before applying the drops. Wait at least 15 minutes after using the medication before putting your lenses back in.
• If you are using other eye medications, wait at least 5 to 10 minutes between applying different products.
• Keep the bottle tightly closed when not in use and store it at room temperature away from moisture and heat.